about
Management of osteoporosis and associated quality of life in post menopausal women.Molecular diagnosis of hypophosphatasia and differential diagnosis by targeted Next Generation Sequencing.Effect of endothelin-1 on osteoblastic differentiation is modified by the level of connexin43: comparative study on calvarial osteoblastic cells isolated from Cx43+/- and Cx43+/+ mice.Medical management of failed back surgery syndrome in Europe: evaluation modalities and treatment proposals.Multicolumn spinal cord stimulation for significant low back pain in failed back surgery syndrome: design of a national, multicentre, randomized, controlled health economics trial (ESTIMET Study).The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells.[Biomarkers of bone remodelling].Microbiological diagnosis of vertebral osteomyelitis: relevance of second percutaneous biopsy following initial negative biopsy and limited yield of post-biopsy blood cultures.Prevalence and distribution of juvenile idiopathic arthritis in a region of Western France.Thiazolidinediones: antidiabetic agents with effects on bone.Sjögren's syndrome with ANCA-associated crescentic extramembranous glomerulonephritis.[Effect of insulin sensitivity on bone mineralization in prepubertal obese children].Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis.Difficulties in the diagnosis of vertebral fracture in men: agreement between doctors.Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis[Bone targeting agents: bisphosphonates].[Are the anatomopathological classifications of primary Gougerot-Sjögren syndrome correlated with each-other and with clinical symptoms?]The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific[Effects of smoking on the thyroid gland, digestive system, kidney and bone]
P50
Q33791246-9810CF03-EAAF-4338-9CEE-51CCE32454E9Q37600843-95E000C2-E535-4AEF-9BFC-22B54242A763Q38346103-64F08F32-3C8D-495D-8923-B52D35E62F61Q38353679-F87C6AA2-6AFF-4A66-876D-2AA25A6CE931Q38419924-1413C22B-77E1-4F1F-97E3-57E23202F95AQ39443734-96E0181E-9F5E-410D-96BF-939B1608C6C0Q43534975-5901171A-3D45-4D79-8C9B-6730C07FEEB9Q43890913-90B2ACAC-B893-4090-90F2-B4BBF09101C1Q45034290-96236F1E-42EF-457E-B18C-FCED26E89E7DQ46053073-0AC4C0CE-E0A0-43A5-BF92-6E412D9CA55BQ46131769-E88D858A-BD63-45F9-B642-2084CE525269Q46288454-5225DA3E-B415-4064-9446-DE2E543D68B1Q47329094-B712A512-35FB-436B-AF27-B8FBBC1569BDQ51119905-EE0E4585-3B57-4D42-BD80-7A39F7991B22Q57779892-FE4CD1B5-9620-4408-AFB8-4C0C0D990723Q64992994-C63904CA-561D-4FF9-99ED-18939AF5888BQ74308211-557C422E-92DE-4BCC-993C-3053F0D65014Q74472261-0AC35C60-CFDC-48AE-8A7A-BB00A239CE91Q83079598-8F2EFD5A-3643-4F0C-BBB9-CDCB1295317E
P50
description
researcher ORCID ID = 0000-0001-6605-3760
@en
wetenschapper
@nl
name
F Debiais
@ast
F Debiais
@en
F Debiais
@es
F Debiais
@nl
type
label
F Debiais
@ast
F Debiais
@en
F Debiais
@es
F Debiais
@nl
prefLabel
F Debiais
@ast
F Debiais
@en
F Debiais
@es
F Debiais
@nl
P106
P1153
7004117611
P31
P496
0000-0001-6605-3760